Mitochondrial Protective Therapeutics for Neurodegenerative & Metabolic Diseases

Time: 11:30 am
day: Day Two


  • Presenting mitochondrial dysfunction as a hallmark mechanism across rare and challenging diseases
  • Examining the importance of mitochondrial homeostasis in high energy systems – CNS, retina, heart, skeletal muscle, kidney
  • Reviewing a novel small molecule approach to treating mitochondrial dysfunction
  • Analyzing preclinical data in ophthalmic indications of retinitis pigmentosa and dry age-related macular degeneration